Use of health and economic impact estimates at Gavi to inform investment decisions and resource mobilization

Home > Use of health and economic impact estimates at Gavi to inform investment decisions and resource mobilization

This presentation runs from 30-42 minutes.

  • PresenterTewodaj Mengistu, Gavi
  • EventIHEA 2023 pre-congress
  • LanguageEnglish

Tewodaj (Todi) Mengistu is a Senior Programme Officer in the Measurement and Strategic Information team at Gavi, the Vaccine Alliance. She supports data and analysis needs for key strategic decisions around Gavi investments and ensures the provision of robust estimates of health and economic impact of Gavi-supported vaccinations. As part of this, she is the Gavi focal point for the Vaccine Impact Modelling Consortium (VIMC), a global consortium aiming to generate disease burden and vaccine impact estimates and to advance the research agenda in the field of vaccine impact modelling.

Todi has a PhD in Policy Analysis (Economics concentration) from the Pardee RAND Graduate School. Prior to Gavi, she worked at the Centres for Disease Control and Prevention (CDC) as a health economist with the Division of Global HIV/AIDS evaluating the effectiveness of delivery services for HIV prevention, care, and treatment in countries with high HIV burden.

tmengistu@gavi.org